What are the side effects of spravato nasal spray?

What are common side effects reported by patients?

The Spravato (esketamine) nasal spray has been linked to a range of potential side effects, according to clinical trial data and patient reports [1]. Common side effects include: dizziness, nausea, increased heart rate, and decreased blood pressure. Many patients experience dissociative sensations, such as feeling detached from their body or experiencing vivid dreams [2].

What are the most serious potential side effects?

In rare cases, Spravato may cause serious side effects, including increased risk of suicidal thoughts and behaviors, increased blood pressure, and cardiovascular events like heart attacks or strokes [3]. It's essential to discuss these risks with a healthcare professional before using the medication.

How does the risk of side effects compare to other similar treatments?

It's worth noting that Spravato has a different chemical makeup than standard antidepressants, and its side effect profile differs as a result. Some patients may experience fewer side effects compared to traditional antidepressants, but others may experience more severe reactions [4]. A comprehensive discussion with a healthcare professional can help determine the best treatment plan for each individual.

Can I take Spravato with other medications?

Taking Spravato with other medications can increase the risk of side effects. Patients should inform their healthcare professional about all medications, including antidepressants, antihistamines, and blood thinners, to ensure safe co-administration [5].

Where can I find more information about Spravato's side effects?

To learn more about Spravato's potential side effects, consult the medication's official prescribing information or visit reputable sources like the FDA website [6] or drugwatch.com [7].

Sources:

[1] FDA. (2020). Spravato Prescribing Information.

[2] ClinicalTrials.gov. (2022). Esketamine Nasal Spray for Treatment-Resistant Depression.

[3] FDA. (2022). Safety Alert: Esketamine (Spravato) May Increase Suicidal Thoughts and Behaviors.

[4] J Clin Psychopharmacol. (2019). Comparative efficacy and safety of esketamine vs. ketamine in treatment-resistant depression: A meta-analysis.

[5] Prescriber's Letter. (2022). Contraindications and interactions with Spravato.

[6] FDA.gov. (n.d.). Spravato.

[7] Drugwatch.com. (2022). Spravato Lawsuit: Esketamine Side Effects.